ALT compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

ALTAltimmune, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

ALTAltimmune, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

ALTAltimmune, Inc.

2.05· pre 2.05· delayed

Mkt cap$396.8MRevenue$26,000Q4 FY25Revenue$41,000FY25

LLYELI Lilly & Co

1,407.25· pre 1,441.98· delayed

Pre-marketNov 4 '26delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

Pre-marketNov 4 '26delayed

ALTAltimmune, Inc.

LLYELI Lilly & Co

2.05pre 2.05delayed

Price

1,407.25pre 1,441.98delayed

$396.8M

Mkt cap

$1.3T

Q4 FY25$26,000

Revenue

$24.4BQ3 FY26

FY25$41,000

Revenue

$65.2BFY25

ALT2.05vsLLY1,407.25Pre-marketNov 4 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

ALT, solidLLY, dashed

Supply-chain overlap

Revenue flow

ALT: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ALT 0

None

Shared 0

No disclosed counterparties: ALT.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Role chip = supplier or customerSource: SEC EDGAR